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Abstract
Water balance disorders after neurosurgery are well rec-
ognized, but detailed reports of the triphasic response are
scarce. We describe a 55-year-old woman, who developed
the triphasic response with severe hyper- and hypona-
traemia after resection of a suprasellar meningioma. The
caseillustrateshowsuddenanddramaticthechangesinwa-
terbalanceafterneurosurgerycanbe.Thebiochemicalpro-
file suggested central diabetes insipidus and the syndrome
ofinappropriateantidiuretichormonesecretion.Theunder-
lyingpathophysiologywasfurtheranalysedusingfractional
excretions, measurements of renin, aldosterone and vaso-
pressin and a metyrapone test. Diagnostic, therapeutic and
preventive strategies for these intriguing but complex cases
are proposed.
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Background
Water balance disorders after neurosurgery are well rec-
ognized and may give rise to hyponatraemia or hyper-
natraemia. Interestingly, water balance disorders can also
develop in a biphasic or even triphasic fashion with re-
ported incidences of 3.4 and 1.1%, respectively [1]. Here,
we present the case study of a 55-year-old female who de-
veloped the triphasic response after a subfrontal resection
of a suprasellar meningioma. Because detailed reports of
the triphasic response are scarce [2,3], our objective was
to analyse its natural course and emphasize the sudden
changes in water balance. In addition, we investigate the
underlying pathophysiology, and formulate strategies for
the management of these cases.
Case report
A55-year-oldfemale(nopreviousmedicalhistory,nomed-
ication) was referred, because a central nervous system
tumour was suspected after she experienced decreased
acuity and blurring of her left eye. Physical examina-
tion was unremarkable (no Cushingoid or acromegalic ap-
pearance, normal female hair pattern). Serum sodium and
endocrine parameters were normal. Magnetic resonance
imaging showed a suprasellar mass that was anatomically
distinctfromthepituitary,compressedthechiasmaopticum
and was enhanced by gadolinium contrast. These findings
suggested the lesion to be a meningioma. She was started
ondexamethasone (4mgfourtimesdaily),andsurgerywas
scheduled. She underwent neurosurgery using a subfrontal
approach to resect the meningioma and decompress the op-
tical and chiasm nerves, while leaving the pituitary stalk
intact (according to the surgical notes). The procedure was
successful, although it involved manipulation of the pitu-
itarystalkand posterior pituitary. Pathological examination
confirmed a transitional meningioma (World Health Orga-
nization Grade I) with a low proliferation index of ∼1%
(immunohistochemistry for MIB-1, a tumour proliferation
marker).
Postoperatively, she developed two polyuric and one an-
tidiureticphases (Figure1).Polyuria(372mL/h)developed
in the first hours after surgery and led to a negative fluid
balance (−2 L) and hypernatraemia (157 mmol/L). The pa-
tient was not hyperglycaemic and did not receive mannitol.
Desmopressin (4 μg intravenously q.d. for 2 days) reduced
polyuria (117 mL/h), raised specific gravity (1024 kg/
L) and, together with intravenous fluids (2 L of dextrose
5% water per day between Days 1 and 2) and ad libitum
drinking, restored normonatraemia (Figure 1).
On the 6th postoperative day (<48 h after hyperna-
traemia), she developed hyponatraemia (serum sodium
128 mmol/L, urine sodium 109 mmol/L, urine osmolal-
ity 809 mOsm/kg). She was clinically euvolaemic, had a
normal kidney function (41 μmol/L) and a low-normal
haematocrit (36%). Additional parameters are shown in
Table 1. Despite the institution of fluid restriction (1–
1.5 L/day), her intake exceeded her marginal urine pro-
duction (19 mL/h), producing a positive fluid balance
(∼+ 1.5 L) and a further fall in haematocrit (35%)
and serum sodium to 121 mmol/L (Figure 1). Although
gross symptoms of hyponatraemia (seizures, coma) were
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Table 1. Laboratory measurements during antidiuretic and polyuric phase
Antidiuretic Polyuric
Measurement Parameters (unit, reference) phase (Day 6) phase (Day 14)
Pituitary hormones TSH (mU/L) (0.4–4.3) 0.113 0.959
LH (U/L) (15–90) 10.4 16.9
FSH (U/L) (35–150) 15.4 40.8
Prolactine (U/L) (0.06–0.93) 0.25 0.14
IGF-1 (nmol/L) (11–31) 17 19.2
Vasopressin (pg/mL) (0.20–4.7)b 0.50 0.31
Adrenal function Renin (μU/mL) (10–60) 15.3 –
Aldosterone (pg/mL) (50–250) 169 –
Response to metyrapone – Normala
Acid-base pH (7.35–7.45) 7.48 –
pCO2, (mmHg) (36–49) 36 –
Bicarbonate (mmol/L) (21–27) 26 –
Base excess (−3t o+3) 3 –
Uric acid and urea Uric acid (mmol/L) (0.12–0.34) 0.09 –
FE uric acid (%) (∼10%) 23 –
FE urea (%) (varies) 41.8 –
aLow cortisol (51 nmol/L, reference 200–800 nmol/L), high adrenocorticotropic hormone (46.2 pmol/L, reference <11 pmol/L), high 11-deoxycortisol
(745 nmol/L, reference after metyrapone >350 nmol/L).
b1 pg/mL corresponds with 1.08 pmol/L vasopressin.
FE, fractional excretion; TSH, thyroid stimulating hormone; FSH, follicle stimulating hormone; LH, luteinising hormone; IGF-1, insulin-like growth
factor-1.
Fig. 1. Triphasic serum sodium course after neurosurgery. Abbreviation:
dDAVP, desamino-D-arginine-vasopressin (synthetic vasopressin).
absent, she was confused, had headaches and unsteadiness
of gait, which resulted in a fall. Because adrenal insuf-
ficiency and/or symptomatic hyponatraemia as a cause
of the collapse could not be ruled out, dexamethasone
(which had been tapered to 2.5 mg three times daily) was
converted to hydrocortisone (10 mg b.i.d.), and treatment
with hypertonic saline was commenced. After discontinu-
ing hypertonic saline at 133 mmol/L, fluid restriction in-
creased serum sodium further to 136 mmol/L (Figure 1).
At this time, the patient again started producing hypotonic
polyuria(specificgravity1001,urineproduction250mL/h)
for which desmopressin (0.1 mg orally) was administered
once. Although this improved her urine concentration abil-
ity (urine osmolality 351 mOsm/kg), she became hyperna-
traemic overnight (serum sodium 154 mmol/L), while still
remainingonfluidrestriction.Afterdesmopressinworeoff,
urine osmolality measured 130 mOsm/kg and urine sodium
22 mmol/L. Ad libitum fluid intake gradually decreased
serum sodium to 147 mmol/L, while urine osmolality re-
mained low (144 mOsm/kg). One year after surgery, she
remainsnormonatraemic(serumsodium142mmol/L)with
the use of desmopressin (0.1 mg b.i.d.). Discontinuation of
desmopressin to evaluate if central diabetes insipidus still
persists has not been tried. Magnetic resonance imaging
showed no recurrence of meningioma, a normal aspect of




ter balance that may occur after neurosurgery. It appeared
that mere manipulation of the pituitary stalk was sufficient
to cause these perturbations, which has been shown be-
fore [4]. However, we cannot exclude the possibility that
physical or vascular injury to the stalk occurred.
The pathophysiology of the triphasic response appears
to be early hypothalamic dysfunction, subsequent release
of vasopressin from the degenerating pituitary and, finally,
depletion of vasopressin stores. Therefore, the two polyuric
phases are consistent with central diabetes insipidus, for
which the dDAVP-responsive hypotonic polyuria was addi-
tional evidence.
Hyponatraemia after neurosurgery is usually attributed
to the syndrome of inappropriate secretion of antidiuretic
hormone (SIADH), although hypocortisolism and cerebral
salt wasting (CSW) have also been reported [4]. A num-
ber of observations favour SIADH in our case, including
the positive fluid balance during the development of hy-
ponatraemia, the tendency towards metabolic alkalosis [5]
and the high fractional excretions of uric acid and urea.
Transient hypopituitarism (see low pituitary hormones, Ta-
ble 1) may have been present, although secondary adrenal
insufficiency seems unlikely, because the patient received
glucocorticoids throughout the postoperative course.
The fact that vasopressin was not suppressed during
hyponatraemia suggests inappropriate secretion or44 E. J. Hoorn and R. Zietse
Table 2. Diagnosis and treatment of dysnatraemia after neurosurgery
Monitoring
A triphasic response (polyuria–antidiuresis–polyuria) can occur after
neurosurgery
Urine output, specific gravity and/or osmolality should be monitored
every 4–6 h in the early postoperative period
To prevent dysnatraemia, changes in urine output and tonicity should
directly lead to appropriate intervention
Serum sodium should be checked between the 6th to 9th postoperative
day for developing hyponatraemia
Diagnosis
In the absence of hyperglycaemia or mannitol, polyuria (3 L/day or
40 mL/kg) with a low urine osmolality (<250 mOsm/kg) is usually
due to central DI, but can also be nephrogenic DI (especially after
subfrontal surgery)
A rise in urine osmolality (100% if complete, 15–50% if partial) after
dDAVP (10 μg nasally or 4 μg i.v.) confirms central DI
Hyponatraemia is usually caused by SIADH, but cerebral salt wasting
and secondary adrenal insufficiency should also be considered
The presence of a metabolic alkalosis and a high FEuric acid (usually
>12%) may help to differentiate SIADH from the other causes
Treatment
Central DI may require (temporary) treatment with dDAVP (initially
10–20 μg nasally 1–2x/day or 0.1–0.2 mg orally 3x/day), while
monitoring serum sodium and urine osmolality
Hyponatraemia due to SIADH may be treated with fluid restriction,
hypertonic saline or perhaps vasopressin-receptor antagonists (little
experience)
dDAVP, desamino-D-arginine-vasopressin (synthetic vasopressin); DI, di-
abetes insipidus; FE, fractional excretion; SIADH, syndrome of inappro-
priate antidiuretic hormone secretion.
leakage. However, urine osmolalities of around
800 mOsm/kg usually correlate with much higher
vasopressin levels (∼4 pg/mL) [6]. Therefore, precursors
of vasopressin or other substances with antidiuretic prop-
erties may have been acting, as was previously reported in
a patient with a macroprolactinoma [6]. In the future, the
analysis of copeptin may be of value, because it is a stable
marker of vasopressin release [7].
It is increasingly recognized that even patients without
gross symptoms of hyponatraemia have central nervous
system impairments that predispose to falls, which may
warrant more aggressive treatment [8]. One option would
be to fluid restrict the patients even more, although some
authors advocate a low threshold for hypertonic saline, es-
pecially after neurosurgery [9]. A new treatment option
are the vasopressin-receptor antagonists, for which the first
successful results in neurosurgery were recently reported
[10].
It has been difficult to identify patients at risk, but
predisposing factors appear to relate both to the disease
(macroadenoma [11], microadenoma, craniopharyngioma,
Rathkecleftcyst[12])andtothesurgery(degreeofmanipu-
lation [4], intraoperative cerebrospinal fluid leak [12]). Our
case demonstrates that even frequent monitoring is some-
times unable to prevent severe dysnatraemia. Successful
prevention probably involves a psychological switch by not
waiting until frank dysnatraemia has developed, but to act
as soon as urine output and tonicity change. This is even
more important, because patients may have impaired thirst
(also in this case: no complete normalization of hyperna-
traemiadespiteadlibitumdrinking,Figure1).Thisrequires
an index of suspicion for treating and consulting physicians
and specific instructions to nursing staff, especially in non-
intensive care settings. Our recommendation is to check for
polyuriaintheimmediatepostoperativeperiod,forhypona-
traemia between Days 6 and 9, and prolong monitoring if
necessaryforthedelayedonsetofcentraldiabetesinsipidus.
These and other management strategies are summarized in
Table 2; we also recommend two recent excellent reviews
[13,14].
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